arBtrage CAPITALIZING MARKETS checking… Sign in

Dyne Therapeutics, Inc.

DYN Health Care Biotechnology: Pharmaceutical Preparations
$17.04
▼ -7.4% Today
as of Jun 7, 07:13 ET
Last 30 days -6.17% Apr 28 → Jun 05
$15.65 $16.64 $17.62 $18.61 $19.60 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$18.09
High
$18.60
Low
$16.63
Volume
$2M
Avg Vol
$3M
Mkt Cap
$3.1B
P/E (TTM)
Beta
52w High
$25.00
52w Low
$8.06
Div Yield
Shares Out
$165M

Overview

52-week range
$8.06
$25
53% of range
Avg surprise (last 2)
-9.0%
Avg reaction (last 2)
+12.5%
100% positive
Latest IV / EM
226%
EM ±31.3% · $18 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.08$-0.99$-0.89$-0.79$-0.70 Actual $-1.08Actual $-0.99Actual $-0.81Actual $-0.70Actual $-0.96Actual $-1.05Est $-0.88Actual $-0.97Actual $-0.76Actual $-0.73Est $-0.74 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-121M$-108M$-95M$-81M$-68M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.73 $-0.74 +1.4% +30.5% +4.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.76 financials
Mon Jun 30, 2025Jun 2025 $-0.97 financials
Thu May 8, 2025Mar/2025 $-1.05 $-0.88 -19.3% +20.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.96 financials
Sun Jun 30, 2024Jun 2024 $-0.70 financials
Sun Mar 31, 2024Mar 2024 $-0.81 financials
Sat Sep 30, 2023Sep 2023 $-0.99 financials
Fri Jun 30, 2023Jun 2023 $-1.08 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-125M$-114M$-116M$-122M$-106M$-72M
Net income$-121M$-108M$-111M$-115M$-97M$-65M
EPS (diluted)$-0.73$-0.76$-0.97$-1.05$-0.96$-0.70

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$753M$893M$574M$485M$472M$435M$532M$608M
Inventory
Total current assets$1.02B$1.13B$806M$698M$690M$659M$736M$792M
Total assets$1.08B$1.19B$867M$729M$721M$691M$769M$826M
Long-term debt
Total liabilities$215M$215M$175M$158M$52M$61M$63M$51M
Total equity$865M$972M$692M$571M$669M$630M$706M$775M

Implied volatility — last 90 days

220%223%225%228%230% Jun 07 — IV 226% · EM ±31.2%

Sector peers